Asieris Pharmaceuticals to Participate at 2017 BIO International Convention

Shanghai, China – June 15, 2017 — Asieris Pharmaceuticals, a clinical stage biopharmaceutical company, announced today that the company will participate at the 2017 Biotechnology Innovation Organization (BIO) International Convention being held on June 19 – 22, 2017, in San Diego, California, USA.

Mr. David Wilson, Senior VP of Business Development, and Ms. Dandan Xie, Senior Business Development Manager of Asieris, will be available to meet with BD professionals from other companies and with investors who are registered to attend the convention. Interested parties are invited to visit Booth 4819 or to contact Asieris through the scheduling system provided by the convention.